| Immunogenic ferroptosis and where to find it? R Demuynck, I Efimova, F Naessens, DV Krysko Journal for immunotherapy of cancer 9 (12), e003430, 2021 | 91 | 2021 |
| A 3D cell death assay to quantitatively determine ferroptosis in spheroids R Demuynck, I Efimova, A Lin, H Declercq, DV Krysko Cells 9 (3), 703, 2020 | 30 | 2020 |
| In vitro veritas: from 2D cultures to organ-on-a-chip models to study immunogenic cell death in the tumor microenvironment DV Krysko, R Demuynck, I Efimova, F Naessens, O Krysko, E Catanzaro Cells 11 (22), 3705, 2022 | 15 | 2022 |
| Immunogenicity of ferroptosis in cancer: a matter of context? E Catanzaro, R Demuynck, F Naessens, L Galluzzi, DV Krysko Trends in cancer 10 (5), 407-416, 2024 | 14 | 2024 |
| Ferroptosis: friend or foe in cancer immunotherapy? R Demuynck, I Efimova, E Catanzaro, DV Krysko OncoImmunology 12 (1), 2182992, 2023 | 11 | 2023 |
| CX3CL1 release during immunogenic apoptosis is associated with enhanced anti-tumour immunity F Naessens, R Demuynck, O Vershinina, I Efimova, M Saviuk, G De Smet, ... Frontiers in Immunology 15, 1396349, 2024 | 3 | 2024 |
| Peripheral blood lymphocytes differ in DNA damage response after exposure to X-rays with different physical properties S Sioen, L D’Hondt, F Van Houte, R Demuynck, K Bacher, C De Wagter, ... International Journal of Radiation Biology 100 (2), 236-247, 2024 | 3 | 2024 |
| Mechanobiology of Ferroptotic Cancer Cells as a Novel “Eat‐Me” Signal: Regulating Efferocytosis through Layer‐by‐Layer Coating L Van der Meeren, I Efimova, R Demuynck, B Parakhonskiy, DV Krysko, ... Advanced healthcare materials 12 (28), 2301025, 2023 | 3 | 2023 |
| Nanomedicine to aid immunogenic cell death (ICD)-based anticancer therapy R Demuynck, Y Engelen, AG Skirtach, SC De Smedt, I Lentacker, ... Trends in cancer, 2024 | 2 | 2024 |
| Mechanobiology of Ferroptotic Cancer Cells as a Novel “Eat-Me” Signal: Regulating Eerocytosis through Layer-by-Layer Coating L Van der Meeren, I Efimova, R Demuynck, B Parakhonskiy, DV Krysko, ... | 1 | 2023 |
| CX3CL1 release is associated with enhanced immunogenicity of dying cancer cells. R Demuynck, F Naessens, O Vershinina, I Efimova, E Catanzaro, ... The Journal of Immunology 212 (1_Supplement), 0881_6274-0881_6274, 2024 | | 2024 |
| Enhancing anti-cancer immunity through immunogenic cell death: the role of endothelial cells in the tumor microenvironment F Naessens, R Demuynck, O Vershinina, I Efimova, E Catanzaro, ... The Journal of Immunology 212 (1_Supplement), 1454_4877-1454_4877, 2024 | | 2024 |
| The DNA damage response of peripheral blood lymphocytes exposed to X-rays with different physical properties S Sioen, L D'hondt, F Van Houte, R Demuynck, K Bacher, C De Wagter, ... 17th International Congress for Radiation Research (ICRR 2023), 2023 | | 2023 |
| Analysis of immunogenic cell death in the tumor microenvironment of tumor spheroids R Demuynck, I Efimova, O Krysko, H Declercq, D Krysko Virtual Immunology 2021™ 206 (Supplement 1), 2021 | | 2021 |
| Cell death stage dictates the immunogenicity of ferroptotic cancer cells I Efimova, E Catanzaro, R Demuynck, L Van der Meeren, F Coppieters, ... American Association of Immunologists 104th Annual Meeting: Virtual …, 2021 | | 2021 |
